Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination
Authors:
- D.G. AddissDAD.G. Addiss
Open Access
- 1 June 1999
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 32 (3) , 325-328
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancroftiTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoesThe Lancet, 1998
- Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian childrenThe Lancet, 1997
- Bacteriologic Studies of Skin, Tissue Fluid, Lymph, and Lymph Nodes in Patients with Filarial LymphedemaThe American Journal of Tropical Medicine and Hygiene, 1997
- Advantages of an annual single dose of ivermectin 400 μg/kg plus diethylcarbamazine for community treatment of bancroftian filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazineTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995